Search results
View David Brabazon’s profile on LinkedIn, a professional community of 1 billion members. Co-Founder AixThera · CFO/Co-Founder Adapt Pharma<br>Non-Executive Director Mainstay Medical...
- 500+
- AixThera Limited
- UCD
- Ireland
Aug 30, 2018 · The others sharing in the windfall are chief financial officer David Brabazon, chief operations officer Eunan Maguire*, chief technology officer Fintan Keegan, the company's top US executive ...
Nov 10, 2013 · Chairman at Mainstay Medical International Ltd., Discover David Brabazon's known position history, network and 52 relationships. Find out about his known public assets.
David Brabazon was a co-founder of Adapt Pharma Limited and served as Chief Financial Officer and a board member. Adapt Pharma Limited is a US focused specialty pharmaceuticals business which was acquired by Emergent BioSolutions Inc. in October 2018.
Jul 21, 2016 · NEW YORK, NY / ACCESSWIRE / July 21, 2016 / Seamus Mulligan, Eunan Maguire and David Brabazon formed Adapt Pharma in 2014, after a $500 Million exit with Azur Pharma. Adapt is focused on...
Aug 29, 2018 · Other Adapt shareholders include Eunan Maguire, listed as an Adapt Pharma co-founder and its chief operating officer, David Brabazon, another co-founder and the company’s chief financial...
Aug 30, 2018 · Séamus Mulligan, an entrepreneur from Waterford, set up Adapt Pharma four years ago with fellow serial pharmaceutical entrepreneurs David Brabazon and Eunan Maguire. The group of pharma investors amassed a cash pile of over $100 million to bankroll the company in its initial stages.
